DPIIT recognised startup Government of India
Startup India
Medicore Generics Private Limited - pharma in Amravati, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.99 Cr
▲ 682% YoY
Net loss · FY 2025
₹1.56 Cr
Net margin -15.6%
EBITDA · FY 2025
₹13.43 Lakh
EBITDA margin 1.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5.73 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
4
As per MCA filings
About Medicore Generics Private Limited
Data last updated:
Medicore Generics Private Limited is a private limited company based in Amravati, Maharashtra, India, recognised as a startup by DPIIT. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 25 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24299MH2021PTC360985. Its GSTIN is 27AAOCM6244P1ZN (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vijay Narayandas Harkut (Whole-Time Director) and Sunil Vamanrao Dhokane (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Ashish V. Harkut Ganesh Colony Shilangaon Road, Amravati, Maharashtra, India – 444601.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.99 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.56 Cr (net margin -15.6%) and EBITDA of ₹13.43 Lakh (EBITDA margin 1.3%).
As per MCA filings, the company has open charges of ₹5.73 Cr on record.
Medicore Generics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-03-0011835). For more details, the company can be reached via its website medicoregenerics.com.
Company Details of Medicore Generics Private Limited
CIN U24299MH2021PTC360985
Registration Number 360985
Incorporation Date 25 May 2021
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-03-0011835
Key People
Vijay Narayandas Harkut Whole-Time Director Sunil Vamanrao Dhokane Whole-Time Director Ashish Vijaykumar Harkut Director Recognitions & Rankings of Medicore Generics
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-03-0011835
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressC/O Ashish V. Harkut Ganesh Colony Shilangaon Road, Amravati, Maharashtra, India – 444601
- IndustryPharma, API Manufacturers
Comprehensive company report
Medicore Generics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Medicore Generics Private Limited
The main business activity of Medicore Generics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medicore Generics Private Limited FY 2025 filings available
Medicore Generics Private Limited reported revenue of ₹9.99 Cr (up 682% YoY) for FY 2025.
Revenue · FY 2025
₹9.99 Cr ▲ 682%
Net loss · FY 2025
₹1.56 Cr margin -15.6%
EBITDA · FY 2025
₹13.43 Lakh margin 1.3%
Compounded Annual Growth Rate (CAGR) of Medicore Generics Private Limited
Revenue CAGR growth
1 year
▲ 682%
EBITDA CAGR growth
1 year
▼ 21%
Revenue rose 682% in the latest year. EBITDA fell 21% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Medicore Generics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹13.43 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.56 Cr | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Medicore Generics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.3% | •••• | •••• | •••• |
| Net Profit Margin | -15.6% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medicore Generics are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Medicore Generics Private Limited
Medicore Generics has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Narayandas Harkut | Whole-Time Director | 15 Apr 2023 | 3 Years 6 Months | Current |
| Ashish Vijaykumar Harkut | Director | 25 May 2021 | 5 Years 4 Months | Current |
| Sunil Vamanrao Dhokane Also directs: Neukey Chemicals and Intermediates LLP | Whole-Time Director | 15 Apr 2023 | 3 Years 6 Months | Current |
| Pankaj Vijaykumar Harkut Also directs: Healthanchor Private Limited, Corazon Healthcare Private Limited, Adsum Hospital Private Limited and 2 more | Director | 25 May 2021 | 5 Years 4 Months | Current |
Peer Comparison of Medicore Generics Private Limited
Medicore Generics Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ven Life Sciences Private Limited | ₹10.79 Cr (FY 2025) | •••• | •••• | 782.0% | •••• | Hyderabad, Telangana, India |
| SRV Biosciences Private Limited | ₹10.41 Cr (FY 2025) | •••• | •••• | 495.0% | •••• | Hyderabad, Telangana, India |
| Vani Organics Private Limited | ₹10.35 Cr (FY 2022) | •••• | •••• | -40.0% | •••• | Bidar, Karnataka, India |
| Sindhu Organics Private Limited | ₹10.08 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Navi Mumbai, Maharashtra, India |
| Deesha Organic Private Limited | ₹10.06 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Vadodara, Gujarat, India |
| Medicore Generics Private Limited this company | ₹9.99 Cr (FY 2025) | •••• | •••• | 682.0% | •••• | Amravati, Maharashtra, India |
| KVB Asta Life Sciences Private Limited | ₹9.9 Cr (FY 2023) | •••• | •••• | 41.0% | •••• | Hyderabad, Telangana, India |
| Techno Drugs and Intermediates Private Limited | ₹9.74 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Mumbai, Maharashtra, India |
| Lakshmi Saras Chemtech Private Limited | ₹9.72 Cr (FY 2024) | •••• | •••• | -56.0% | •••• | Hyderabad, Telangana, India |
| Tyndal Labs Private Limited | ₹9.69 Cr (FY 2024) | •••• | •••• | -58.0% | •••• | Paravada, Andhra Pradesh, India |
| Sri Sai Uma Laboratories Private Limited | ₹9.69 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Medicore Generics by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medicore Generics Private Limited
Medicore Generics Private Limited is audited by ARTH & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARTH & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Medicore Generics Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medicore Generics Private Limited
Open charges
₹5.73 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2022 | Others | ₹5.73 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Medicore Generics Private Limited
Medicore Generics Private Limited has a workforce of 0 employees as of Mar 28, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medicore Generics Private Limited
Medicore Generics Private Limited has 6 board changes on record since 2021: 4 appointments and 2 cessations. The latest: Narendra Shriram Joshi ceased to be Whole-Time Director on 08 Oct 2024.
AGM
Medicore Generics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medicore Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Ceased
Narendra Shriram Joshi ceased to be Whole-Time Director.
Appointed
Sunil Vamanrao Dhokane was appointed as Whole-Time Director.
Appointed
Vijay Narayandas Harkut was appointed as Whole-Time Director.
Charges
A charge with Others amounted to Rs. 573.00 Lakh with Charge ID 100658811 was registered on 13 Oct 2022.
Ceased
Aditya Omprakash Bhutada ceased to be Director.
Appointed
Ashish Vijaykumar Harkut was appointed as Director.
Appointed
Pankaj Vijaykumar Harkut was appointed as Director.
Incorporation
25 May 2021
Medicore Generics Private Limited was registered on 25 May 2021 with Roc Nagpur & aged 5 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Medicore Generics Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medicore Generics Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medicore Generics Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medicore Generics Private Limited
Medicore Generics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCM6244P1ZN | Maharashtra | Active | 20 Aug 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medicore Generics Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicore Generics Private Limited
Medicore Generics is an active private limited company based in Amravati, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 25 May 2021 (5+ years old) and is registered under CIN U24299MH2021PTC360985.
Medicore Generics reported revenue of ₹9.99 Cr for FY 2025 (up 682% YoY).
Medicore Generics has 4 current directors:
- Vijay Narayandas Harkut - Whole-Time Director
- Sunil Vamanrao Dhokane - Whole-Time Director
- Ashish Vijaykumar Harkut - Director
- Pankaj Vijaykumar Harkut - Director
Medicore Generics reported a net loss of ₹1.56 Cr (net margin -15.6%) and EBITDA of ₹13.43 Lakh (EBITDA margin 1.3%) for FY 2025, as per its filed financial statements.
The GSTIN of Medicore Generics is 27AAOCM6244P1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medicore Generics is U24299MH2021PTC360985. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicore Generics was incorporated on 25 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Medicore Generics by revenue are Ven Life Sciences Private Limited, SRV Biosciences Private Limited, Vani Organics Private Limited, Sindhu Organics Private Limited, Deesha Organic Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Narendra Shriram Joshi ceased to be Whole-Time Director on 08 Oct 2024. Sunil Vamanrao Dhokane was appointed as Whole-Time Director on 15 Apr 2023. Vijay Narayandas Harkut was appointed as Whole-Time Director on 15 Apr 2023. Medicore Generics has 6 board changes on record in total.
Yes, Medicore Generics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Medicore Generics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-03-0011835).